Constitutive acid sphingomyelinase enhances early and late macrophage killing of Salmonella enterica serovar Typhimurium.
We have identified acid sphingomyelinase (ASM) as an important player in the early and late anti-Salmonella activity of macrophages. A functional ASM participated in the killing activity of macrophages against wild-type Salmonella enterica serovar Typhimurium. The role of ASM in early macrophage killing of Salmonella appears to be linked to an active NADPH phagocyte oxidase enzymatic complex, since the flavoprotein inhibitor diphenyleneiodonium not only blocked a productive respiratory burst but also abrogated the survival advantage of Salmonella in macrophages lacking ASM. Lack of ASM activity also increased the intracellular survival of an isogenic DeltaspiC::FRT Salmonella strain deficient in a translocator and effector of the Salmonella pathogenicity island 2 (SPI2) type III secretion system, suggesting that the antimicrobial activity associated with ASM is manifested regardless of the SPI2 status of the bacteria. Constitutively expressed ASM is responsible for the role that this lipid-metabolizing hydrolase plays in the innate host defense of macrophages against Salmonella. Accordingly, the ASM activity and intracellular concentration and composition of ceramide, gangliosides, and neutral sphingolipids did not increase upon Salmonella infection. Salmonella triggered, nonetheless, a significant increase in the secreted fraction of ASM. Collectively, these findings have elucidated a novel role for constitutive ASM in the anti-Salmonella activity of murine macrophages.
McCollister
Bruce D
BD
Department of Microbiology, Mail Box 8333, UCHSC School of Medicine at Fitzsimons, P.O. Box 6511, Room P18-9120, Aurora, CO 80010, USA.
Myers
Jesse T
JT
Jones-Carson
Jessica
J
Voelker
Dennis R
DR
Vázquez-Torres
Andrés
A
D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics; D002518:Ceramides / Q000032:analysis; D003600:Cytosol / Q000737:chemistry; D005732:Gangliosides / Q000032:analysis; D008264:Macrophages / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D050296:Microbial Viability / Q000276:immunology*; D019255:NADPH Oxidases / Q000037:antagonists & inhibitors / Q000276:immunology; D017382:Reactive Oxygen Species / Q000378:metabolism; D012486:Salmonella typhimurium / Q000276:immunology*; D013107:Sphingolipids / Q000032:analysis; D013108:Sphingomyelin Phosphodiesterase / Q000172:deficiency / Q000235:genetics / Q000276:immunology* / Q000378:metabolism
D001426:Bacterial Proteins; D002518:Ceramides; D005732:Gangliosides; D017382:Reactive Oxygen Species; D013107:Sphingolipids; C120280:SpiC protein, Salmonella; D019255:NADPH Oxidases; C112980:acid sphingomyelinase-1; D013108:Sphingomyelin Phosphodiesterase
J Immunol. 2003 Mar 1;170(5):2621-8
12594290
J Immunol. 2001 May 1;166(9):5741-8
11313417
J Exp Med. 2000 Jul 17;192(2):227-36
10899909
J Exp Med. 2005 Sep 5;202(5):625-35
16129704
Methods Enzymol. 2008;437:521-38
18433645
Mol Microbiol. 1998 Oct;30(1):175-88
9786194
Science. 1995 Jul 21;269(5222):400-3
7618105
Nat Genet. 1995 Jul;10(3):288-93
7670466
Microbes Infect. 2001 Nov-Dec;3(14-15):1313-20
11755420
J Exp Med. 2002 May 6;195(9):1155-66
11994420
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13997-4001
9391141
J Bacteriol. 2002 Sep;184(18):4971-80
12193612
J Lipid Res. 2002 May;43(5):815-23
11971953
Infect Immun. 2005 Oct;73(10):6260-71
16177297
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7800-4
8755556
Cell. 1997 Nov 28;91(5):605-15
9393854
EMBO J. 1999 Oct 1;18(19):5252-63
10508159
J Pediatr. 2000 Nov;137(5):687-93
11060536
J Biol Chem. 1998 Jan 30;273(5):2738-46
9446580
J Immunol. 2004 May 15;172(10):6202-8
15128808
J Bacteriol. 1990 May;172(5):2485-90
2185222
J Exp Med. 2000 Jul 17;192(2):237-48
10899910
Traffic. 2006 Jun;7(6):716-30
16637890
J Cell Biol. 1997 Apr 7;137(1):93-104
9105039
Nature. 1999 Oct 21;401(6755):804-8
10548107
Infect Immun. 1991 Jul;59(7):2232-8
2050395
EMBO J. 1999 Jul 15;18(14):3924-33
10406797
Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2593-7
8637919
Science. 2000 Mar 3;287(5458):1655-8
10698741
Methods Enzymol. 2000;312:64-79
11070863
Annu Rev Physiol. 1998;60:643-65
9558480
Eur J Immunol. 2000 Mar;30(3):944-53
10741413
Proc Natl Acad Sci U S A. 1986 Jul;83(14):5189-93
3523484
Annu Rev Immunol. 2005;23:197-223
15771570
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2561-5
11226278
Cell Microbiol. 2002 Aug;4(8):531-40
12174087
Infect Immun. 1989 Jan;57(1):1-7
2642463
J Exp Med. 1997 Aug 18;186(4):569-80
9254655
FEBS Lett. 2000 Aug 4;478(3):260-6
10930579
Trop Doct. 2004 Oct;34(4):198-200
15510940
J Cell Sci. 1997 Sep;110 ( Pt 18):2303-14
9378779
Nature. 1974 Mar 22;248(446):345-7
4594698
Mol Microbiol. 2003 Apr;48(2):401-15
12675800
EMBO J. 2003 Oct 1;22(19):5003-14
14517239
Trans R Soc Trop Med Hyg. 2000 May-Jun;94(3):310-4
10975008
Nat Med. 2003 Mar;9(3):322-30
12563314